These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
206 related articles for article (PubMed ID: 1292582)
1. Effect of simvastatin on high density lipoprotein subfractions and apolipoproteins in type IIa hypercholesterolemia. Crook D; Bruce R; Worthington M; Mulcahy D; Patterson D; Wynn V Cardiovasc Drugs Ther; 1992 Dec; 6(6):633-9. PubMed ID: 1292582 [TBL] [Abstract][Full Text] [Related]
2. Effects of long-term treatment with simvastatin on plasma lipids and lipoproteins in patients with primary hypercholesterolemia. Thiery J; Creutzfeldt C; Creutzfeldt W; Walli AK; Seidel D Klin Wochenschr; 1990 Aug; 68(16):814-22. PubMed ID: 2214604 [TBL] [Abstract][Full Text] [Related]
3. Plasma high density lipoprotein particle size alteration by simvastatin treatment in patients with hypercholesterolaemia. Johansson J; Mölgaard J; Olsson AG Atherosclerosis; 1991 Dec; 91(3):175-84. PubMed ID: 1789802 [TBL] [Abstract][Full Text] [Related]
4. Effects of combination therapy with estrogen plus simvastatin on lipoprotein metabolism in postmenopausal women with type IIa hypercholesterolemia. Wakatsuki A; Okatani Y; Ikenoue N Atherosclerosis; 2000 May; 150(1):103-11. PubMed ID: 10781640 [TBL] [Abstract][Full Text] [Related]
5. Comparison of the efficacy of simvastatin and standard fibrate therapy in the treatment of primary hypercholesterolemia and combined hyperlipidemia. Bruckert E; De Gennes JL; Malbecq W; Baigts F Clin Cardiol; 1995 Nov; 18(11):621-9. PubMed ID: 8590530 [TBL] [Abstract][Full Text] [Related]
6. Multicenter comparison of micronized fenofibrate and simvastatin in patients with primary type IIA or IIB hyperlipoproteinemia. Steinmetz A; Schwartz T; Hehnke U; Kaffarnik H J Cardiovasc Pharmacol; 1996 Apr; 27(4):563-70. PubMed ID: 8847874 [TBL] [Abstract][Full Text] [Related]
7. Effect of simvastatin on the apparent size of LDL particles in patients with type IIB hyperlipoproteinemia. Zhao SP; Hollaar L; van 't Hooft FM; Smelt AH; Gevers Leuven JA; van der Laarse A Clin Chim Acta; 1991 Dec; 203(2-3):109-17. PubMed ID: 1777975 [TBL] [Abstract][Full Text] [Related]
8. Comparison between simvastatin and bezafibrate in effect on plasma lipoproteins and apolipoproteins in primary hypercholesterolaemia. Schulzeck P; Bojanovski M; Jochim A; Canzler H; Bojanovski D Lancet; 1988 Mar; 1(8586):611-3. PubMed ID: 2894548 [TBL] [Abstract][Full Text] [Related]
9. Low-dose effect of simvastatin (MK-733) on serum lipids, lipoproteins, and apolipoproteins in patients with hypercholesterolemia. Saku K; Sasaki J; Arakawa K Clin Ther; 1989; 11(2):247-57. PubMed ID: 2736571 [TBL] [Abstract][Full Text] [Related]
10. Effects of simvastatin on plasma lipid, lipoprotein and apolipoprotein concentrations in hypercholesterolaemia. Mölgaard J; von Schenck H; Olsson AG Eur Heart J; 1988 May; 9(5):541-51. PubMed ID: 3402470 [TBL] [Abstract][Full Text] [Related]
12. Effects of simvastatin and fenofibrate on serum lipoproteins and apolipoproteins in primary hypercholesterolaemia. Stohler R; Keller U; Riesen WF Eur J Clin Pharmacol; 1989; 37(2):199-203. PubMed ID: 2507323 [TBL] [Abstract][Full Text] [Related]
13. Clinical experience with simvastatin compared with cholestyramine. Erkelens DW; Baggen MG; Van Doormaal JJ; Kettner M; Koningsberger JC; Mol MJ Drugs; 1988; 36 Suppl 3():87-92. PubMed ID: 3254824 [TBL] [Abstract][Full Text] [Related]
14. [Simvastatin in the treatment of familial hypercholesterolemia]. Ceska R; Sobra J; Procházková R; Kvasilová M Cas Lek Cesk; 1995 May; 134(10):310-3. PubMed ID: 7788650 [TBL] [Abstract][Full Text] [Related]
15. The effect of dietary fat content on plasma noncholesterol sterol concentrations in patients with familial hypercholesterolemia treated with simvastatin. Chisholm A; Sutherland W; Ball M Metabolism; 1994 Mar; 43(3):310-4. PubMed ID: 8139479 [TBL] [Abstract][Full Text] [Related]
16. Simvastatin (MK 733) in heterozygous familial hypercholesterolemia: a two-year trial. Leclercq V; Harvengt C Int J Clin Pharmacol Ther Toxicol; 1989 Feb; 27(2):76-81. PubMed ID: 2921098 [TBL] [Abstract][Full Text] [Related]
17. A comparative study of the efficacy of simvastatin and gemfibrozil in combined hyperlipoproteinemia: prediction of response by baseline lipids, apo E genotype, lipoprotein(a) and insulin. Nestel P; Simons L; Barter P; Clifton P; Colquhoun D; Hamilton-Craig I; Sikaris K; Sullivan D Atherosclerosis; 1997 Mar; 129(2):231-9. PubMed ID: 9105566 [TBL] [Abstract][Full Text] [Related]
18. Effects of fluvastatin on lipid profile and apolipoproteins in Chinese patients with hypercholesterolemia. Tomlinson B; Mak TW; Tsui JY; Woo J; Shek CC; Critchley JA; Masarei JR Am J Cardiol; 1995 Jul; 76(2):136A-139A. PubMed ID: 7604789 [TBL] [Abstract][Full Text] [Related]
19. Effects of nicotinic acid therapy on plasma lipoproteins and very low density lipoprotein apoprotein C subspecies in hyperlipoproteinemia. Yovos JG; Patel ST; Falko JM; Newman HA; Hill DS J Clin Endocrinol Metab; 1982 Jun; 54(6):1210-5. PubMed ID: 7076797 [TBL] [Abstract][Full Text] [Related]
20. [Effectiveness, tolerance and safety of simvastatin in comparison with bezafibrate in treatment of hypercholesterolemia]. Lechleitner M; Sailer S; Irsigler H; Klein W; Patsch JR Wien Med Wochenschr; 1995; 145(21):577-83. PubMed ID: 8560901 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]